# Danicopan PMS in Korea

> **NCT07457151** · — · RECRUITING · sponsor: **AstraZeneca** · enrollment: 8 (estimated)

## Conditions studied

- Paroxysmal Nocturnal Hemoglobinuria

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07457151
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-10
- **Primary completion:** 2028-06-27
- **Final completion:** 2028-06-27
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07457151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07457151, "Danicopan PMS in Korea". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07457151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*